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Abstract
Introduction: In this study, we sought describe the incidence and outcomes of severe metabolic or mixed
acidemia in critically ill patients as well as the use of sodium bicarbonate therapy to treat these illnesses.
Methods: We conducted a prospective, observational, multiple-center study. Consecutive patients who presented
with severe acidemia, defined herein as plasma pH below 7.20, were screened. The incidence, sodium bicarbonate
prescription and outcomes of either metabolic or mixed severe acidemia were analyzed.
Results: Among 2, 550 critically ill patients, 200 (8%) presented with severe acidemia, and 155 (6% of the total
admissions) met the inclusion criteria. Almost all patients needed mechanical ventilation and vasopressors during
their ICU stay, and 20% of them required renal replacement therapy within the first 24 hours of their ICU stay.
Severe metabolic or mixed acidemia was associated with a mortality rate of 57% in the ICU. Delay of acidemia
recovery as opposed to initial pH value was associated with increased mortality in the ICU. The type of acidemia
did not influence the decision to administer sodium bicarbonate.
Conclusions: The incidence of severe metabolic or mixed acidemia in critically ill patients was 6% in the present
study, and it was associated with a 57% mortality rate in the ICU. In contradistinction with the initial acid-base
parameters, the rapidity of acidemia recovery was an independent risk factor for mortality. Sodium bicarbonate
prescription was very heterogeneous between ICUs. Further studies assessing specific treatments may be of
interest in this population.
Introduction
“Acidemia” can be defined as the accumulation of pro-
tons in the plasma which results in a lower blood pH if
secondary responses are overwhelmed. In critically ill
patients, acidosis is often the result of a combination of
single disorders occurring simultaneously that are com-
monly known collectively as “mixed acid-base disorders”
[1-6].
Although “severe acidemia” is not a universally
accepted term, it usually indicates that plasma pH is
lower than 7.20 [3,7,8]. Severe acidemia can be critical,
especially when an extremely low pH develops quickly.
Clinical manifestations of severe acidemia include cere-
bral edema, seizures, diaphragm dysfunction [9],
decreased myocardial contractility, pulmonary vasocon-
striction and systemic vasodilatation [3,10,11]. Acidemia
is a potentially life-threatening condition, and previous
studies have described the incidence and mechanisms of
acidosis occurring in the ICU [1,12,13]. Surprisingly,
however, these studies failed to focus specifically on
severe acidemia. Furthermore, despite the fact that
* Correspondence: s-jaber@chu-montpellier.fr
1Intensive Care Unit, Department of Anaesthesia and Critical Care, Saint Eloi
Teaching Hospital, Université Montpellier 1, 80 avenue Augustin Fliche, F-
34295 Montpellier, Cedex 5, France
Full list of author information is available at the end of the article
Jung et al. Critical Care 2011, 15:R238
http://ccforum.com/content/15/5/R238
© 2011 Jung et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/Licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.severe acidemia reflects a serious underlying disease that
should be treated as soon as possible, the treatment of
acidemia by itself with the administration of intravenous
buffers remains controversial [7,8,14,15]. Indeed, not-
withstanding experts’ opinions arguing against treatment
with intravenous buffers except in dedicated situations
(for example, massive digestive fluid loss during diarrhea
or tubular acidosis) [16], 86% of polled US nephrologists
indicated that they would prescribe buffers to treat lactic
acidosis in patients with a targeted pH above 7.20 [8].
Moreover, the Surviving Sepsis Campaign suggests not
treating lactic acidosis when the plasma pH level is
above 7.15, but does not give any recommendations for
cases where the plasma pH level is below this threshold
[7]. To date there have been only two small, prospective,
randomized crossover studies assessing the impact of
sodium bicarbonate treatment for lactic acidosis on
hemodynamic, acid-base and electrolyte changes [14,15].
Both studies included 24 patients and could not address
any difference in terms of morbidity and mortality with
regard to whether the patients had first been treated
with sodium bicarbonate.
Therefore, we had two aims in our study. First, we
sought to describe the incidence of severely metabolic
or mixed acidemia patients admitted to the ICU. Sec-
ond, we wanted to describe the outcomes of patients
who had been treated at the onset of acidemia (within
the first 24 hours of ICU admission) with intravenous
sodium bicarbonate compared with those who had not.
We hypothesized that severe acidosis within the 24 first
hours after ICU admission is an infrequent phenomenon
but that its correction rather than its initial severity is
associated with prognosis.
Materials and methods
This prospective, multiple-center study was conducted
during a thirteen-month period in five ICUs. In accor-
dance with French law, informed consent was not man-
datory, given that this observational study did not
modify diagnostic or therapeutic strategies. This study
was approved by the Montpellier University Hospital
Institutional Review Board and followed the Strengthen-
ing the Reporting of Observational Studies in Epidemiol-
ogy recommendations for reporting observational
studies [17].
Definitions
“Severe acidemia” was defined as a pH below 7.20.
Respiratory acidosis, metabolic acidosis and other mixed
disorders were categorized using the classical method
(namely, the Henderson-Hasselbalch equation) with base
excess and corrected anion gap (AG) (corrected AG =
(measured AG + (40 g/dl - (albuminemia ÷ 10 g/dl)))
[3,18,19].
Therefore, we defined the following specific acidemia
as follows. (1) “Severe metabolic acidemia” comprised
pH less than 7.20, bicarbonatemia less than 22 mmol/L,
base excess less than or equal to 5 mmol/L and
expected partial pressure of carbon dioxide (PaCO2)=
b i c a r b o n a t e m i a×1 . 5+8±2m m H g[ 1 8 ] .( 2 )“Severe
respiratory acidemia” was defined as pH less than 7.20,
PaCO2 greater than 45 mmHg and expected bicarbona-
temia = (PaCO2 - 40) ÷ 10 + 24). (3) “Severe mixed
acidemia” was the classification for secondary response
to the primary process outside the expected range.
Patients
All consecutive patients who experienced severe acide-
mia within the first 24 hours of their ICU admission
were screened, and those who presented with either sin-
gle metabolic acidemia or mixed metabolic and respira-
tory acidemia were included. Patients admitted for
diabetic ketoacidosis were excluded from the outcome
analysis, as their mortality risk in the ICU is very low
and may not represent the risk level among the whole
population [20]. Furthermore, because one of the aims
of the present study was to describe the use of sodium
bicarbonate to treat severe acidemia, patients admitted
with a single severe respiratory acidemia were not ana-
lyzed in detail, because they were considered not to be
candidates for that treatment. No guidelines, advice or
documentation were given to the intensivists regarding
acidemia, treatment or routine daily care.
Measured parameters
Upon their admission to the ICU, we documented
patients’ baseline characteristics, SAPS II [21], SOFA
[22] severity scores and the reason for admission to the
ICU (Table 1). Within the first 48 hours of their ICU
stay, we recorded patients’ arterial blood pH, PaCO2,
bicarbonate concentration, standard base excess, creati-
nine, sodium, potassium, chloride, albumin and lactate
(Lac). Apparent strong ion differences were calculated
as plasma concentrations: [Na
+]+[ K
+]+[ M g
2+] + [Ca
2
+]-[ C l
-]-[ L a c
-]. Effective strong ion differences were
calculated as plasma concentrations: 2.46 × 10
pH 8 ×
PaCO2 + [albumin] × (0.123 × pH - 0.631) + [phos-
phate] × 0.309 × pH - 0.469] (all concentrations are
expressed as mEq/L). The strong ion gap was calculated
as the difference between apparent and effective strong
ion data [5]. Moreover, we recorded the amount of
sodium bicarbonate administered, the amount of
required vasopressors and the need for renal replace-
ment therapy, intubation and mechanical ventilation.
We also documented the duration of mechanical venti-
lation and use of vasopressors while in the ICU, the
length of ICU stay, and mortality. The primary end
point was the mortality rate at ICU discharge. The
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mechanical ventilation in the ICU, the duration of vaso-
pressor use and the overall length of ICU stay.
Statistics
Data are expressed as means ± SD or medians and 95%
CI for continuous variables and raw numbers and per-
centages for categorical variables. Two main compari-
sons were performed. First, we compared survivors to
nonsurvivors. Second, we compared patients treated
with sodium bicarbonate to those who were not. Con-
tinuous data were compared using a Student’s t-test or
a Mann-Whitney U test regarding the normality of the
population distribution. A Χ
2 test was used for categori-
cal variables. Comparisons of several means were per-
formed using repeated-measures analysis of variance
and the Tukey’s post hoc test. Multivariate analyses were
performed using a logistic regression model with
forward selection procedures to estimate the odds ratio
of death (with the 95% CI) after discretization of the
continuous variables according to their median values
and also to describe the prescription of sodium bicarbo-
nate. Calibration of the logistic model was assessed
using the Hosmer-Lemeshow goodness-of-fit test to
evaluate the importance of the discrepancy between
observed and expected mortality. Each variable asso-
ciated with a P value below 0.20 in the univariate analy-
sis was entered into the model. All values were two-
tailed, and P < 0.05 was considered statistically signifi-
cant. Statistical analysis was performed with MedCalc
version 9.4.2.0 statistical software (MedCalc Software
bvba, Mariakerke, Belgium).
Results
During the study period, 2, 550 patients were admitted
to the five participating ICUs. Among those patients,
Table 1 Characteristics and main outcomes of the study population
Characteristics All patients
(n = 155)
Survivors
(n = 66)
Nonsurvivors
(n = 89)
P value
Age (years) 63 ± 16 62 ± 16 67 ± 15 < 0.01
Males 99 (64) 41 (62) 58 (65) 0.74
Body mass index (kg/m
2) 26 ± 6 26 ± 5 27 ± 7 0.43
SAPS II upon ICU admission 67 ± 22 53 ± 16 76 ± 21 < 0.01
SOFA upon ICU admission 10 ± 4 9 ± 4 12 ± 4 < 0.01
Admitting diagnosis group
Septic shock 54 (35) 25 (37) 29 (33) 0.53
Hemorrhagic shock 16 (11) 5 (8) 11 (12) 0.48
Cardiogenic shock 11 (7) 3 (5) 8 (9) 0.45
Cardiac arrest 19 (12) 5 (8) 14 (16) 0.20
Multiple trauma 10 (6) 5 (8) 5 (6) 0.74
Acute respiratory failure 19 (12) 7 (10) 12 (13) 0.63
Acute renal failure 4 (3) 4 (6) 0 (0) 0.03
Others 22 (14) 12 (18) 10 (11) 0.25
Vasopressor administration upon ICU admission 130 (83) 49 (74) 81 (91) 0.01
Renal replacement therapy within first 24 hours of ICU stay 31 (20) 12 (18) 19 (21) 0.69
Mechanical ventilation within first 24 hours of ICU stay 135 (88) 54 (82) 81 (91) 0.15
Creatininemia upon ICU admission (μmol/L) 200 ± 134 213 ± 166 188 ± 100 0.81
Albuminemia upon ICU admission (g/L) 23 ± 8 25 ± 9 21 ± 7 0.01
Base excess upon ICU admission (mmol/L) -13.7 ± 6.1 -12.4 ± 6.1 -14.6 ± 5.9 < 0.01
Anion gap upon ICU admission (mmol/L) 23 ± 10 21 ± 10 25 ± 9 < 0.01
Apparent strong ion difference upon ICU admission (mEq/L) 32.4 ± 6.0 35.4 ± 6.5 34.5 ± 5.8 0.16
Effective strong ion difference upon ICU admission (mEq/L) 22.3 ± 6.0 24.9 ± 6.1 22.4 ± 6.0 0.04
Strong ion gap upon ICU admission (mEq/L) 10.4 ± 6.3 10.8 ± 6.4 12.1 ± 5.3 0.21
Sodium bicarbonate administration within first 24 hours of ICU stay 57 (37) 23 (35) 34 (38) 0.73
Amount of sodium bicarbonate administered within first 24 hours of ICU stay in
patients receiving sodium bicarbonate (mmol/kg)
3.9 ± 3.2 3.0 ± 2.0 4.0 ± 2.8 0.31
Length of mechanical ventilation (days) 3 [2 to 11] 4 [3 to 6] 2 [2 to 3] 0.04
Length of vasopressor administration (days) 2 [1 to 5] 3 [2 to 4] 2 [2.0 to 2.1] 0.38
Length of ICU stay (days) 5 [2 to 13] 11 [8 to 17] 2 [2 to 3] < 0.01
SAPS II = Severity Acute Physiology Score II [22]; SOFA = Sequential Organ Failure Assessment [23]. Categorical data are expressed as raw numbers (%).
Continuous data are expressed as means ± SD. All other data are medians [range]. Comparisons were made between survivors and nonsurvivors.
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Page 3 of 9200 consecutive patients (8%) with severe acidemia (pH
< 7.20) were screened. Among those 200 patients, 35
(18%) exhibited a single respiratory acidemia. Among
those 35 patients, 12 died (34%) and they were not
further analyzed. Ten patients admitted for ketoacidosis
were discharged alive and were not further analyzed
(Figure 1).
Next, 155 patients (6% of the 2, 550 screened patients)
were eligible for the prognostic analysis. Their charac-
teristics are presented in Table 1. Eighty-four patients
(54%) were intubated upon ICU admission, and one
hundred thirty-five (88%) were intubated within the first
24 hours of their stay. During their stay, 90% of all
patients required mechanical ventilation and vasopres-
sors, 31 (20%) required renal replacement therapy within
the first 24 hours of admission and 89 (57%) died during
their ICU stay. No difference in terms of diagnosis was
observed between survivors and nonsurvivors (Table 1).
Conversely, older age, higher SAPS II or SOFA score
and vasopressor requirement within the first 24 hours of
admission were associated with mortality (Table 1).
Although admission pH and bicarbonatemia were simi-
lar regardless of intubation status, lactatemia was signifi-
cantly lower in the nonintubated patients than in those
who were intubated (4.1 ± 4.1 mmol/L vs 8.7 ± 6.1
mmol/L; P = 0.01).
Figures 2A to 2F show the daily evaluation of acid-
base and lactate parameters according to ICU survival.
On the acid-base parameters, lactatemia and anion gap
upon ICU admission were higher in nonsurvivors than
in survivors (Table 1 and Figures 2E and 2F). Interest-
ingly, although pH, plasma bicarbonate level and base
excess were similar between survivors and nonsurvivors
upon ICU admission, plasma pH remained lower in
nonsurvivors than in survivors during the first 48 hours
of the ICU stay (Additional file 1, Figure S1). We also
analyzed acid-base balance according to the use of renal
replacement therapy within the first 48 hours after ICU
admission. After exclusion of patients receiving sodium
bicarbonate infusion, there was not any significant pH
variation between day 1 and day 0 according to the pre-
scription of renal replacement therapy. Indeed, pH var-
iation was 0.15 ± 0.14 among the 27 patients on renal
replacement therapy compared to 0.18 ± 0.17 among
the 73 patients off renal replacement therapy.
Among the 155 included patients, 57 were treated
symptomatically with sodium bicarbonate within the
first 24 hours of their stay in the ICU (Table 2). No dif-
ference was observed between patients treated or not
treated with sodium bicarbonate regarding ICU admis-
sion diagnosis, acidosis mechanism, severity score and
necessity of vasopressors or mechanical ventilation. In
logistic regression, base excess was the sole parameter
associated with sodium bicarbonate administration (OR
= 0.91, 95% CI = 0.85 to 0.97; P = 0.005). Among the
98 patients who were not treated with sodium bicarbo-
nate within the 24 first hours of their ICU stay, 6 were
f i n a l l yt r e a t e da f t e r2 4h o u r sa n d3o ft h e md i e di nt h e
ICU.
Bicarbonate administration ranged from 5% of the
patients in one ICU to 55% in another one, depending
mostly on the center delivering treatment rather than
on the acidemia mechanism. When used, the concentra-
tion of sodium bicarbonate was 3.5 ± 3.3 mmol/L within
the first 24 hours and ranged from 250 ml of 1.4% solu-
tion to 4, 000 ml of 4.2% solution, with no statistical dif-
ference observed between survivors and nonsurvivors.
The severity of acidemia was not associated with the fre-
quency of sodium bicarbonate prescription, but lower
plasma bicarbonate, base excess, PaCO2 and higher cor-
rected anion gap were associated with sodium bicarbo-
nate administration (Table 2). The different outcome
parameters were not different on the basis of early pre-
scription of sodium bicarbonate (Table 2). Multivariate
analysis showed that although plasma pH upon ICU
admission was not a predictor of outcome, the persis-
tence of a low plasma pH after 24 hours in the ICU was
an independent risk factor for mortality in the ICU
(Table 3). Additional details are provided in the Addi-
tional file 1.
Discussion
The main results of this study can be summarized as
follows. First, severe metabolic or mixed acidemia
defined by a plasma pH level lower than 7.20 within the
first 24 hours of ICU admission was observed in 6% of
critically ill patients. Second, severe metabolic or mixed
acidemia was associated with an ICU mortality rate of
57%. Third, as opposed to pH value, the rapidity of acid-
emia correction was associated with mortality. Fourth,
sodium bicarbonate prescription within the first 24
hours of acidemia was heterogeneous, depending on the
participating ICU, and was not associated with the
patient’s prognosis.
Several limitations of this study must be identified.
First, we defined and classified severe acidemia on the
basis of a pH value below 7.20, bicarbonate and base
excess [3,18,19], and instead used the physiochemical
classification developed by Stewart [1,23]. We chose this
strategy because of its widespread use and because it
was the easiest way to screen patients [6,24]. Moreover,
our study could not demonstrate that acidemia per se
rather than the underlying disease was the main inde-
pendent predictive factor in patient outcome. Indeed,
our study was an observational, multiple-center study
which included all consecutive, heterogeneous patients
according to their acid-base status and was not designed
to specifically address the impact of sodium bicarbonate
Jung et al. Critical Care 2011, 15:R238
http://ccforum.com/content/15/5/R238
Page 4 of 9on outcome or to address the reasons for sodium bicar-
bonate prescription. We also could not assess whether
very early sodium bicarbonate administration (within
the first six hours of acidemia), a different load of buffer
(high vs low dose) or administration modalities (slow vs
rapid infusion and/or concentrated vs diluted bicarbo-
nate) had any different effects on outcome. However,
t h ep r e s e n tc o h o r tm a yb eu s e da sat o o lw i t hw h i c ht o
design a future interventional, randomized study to
examine the effects of buffers in severely acidotic criti-
cally ill patients.
Although acidosis is a common concern in critically ill
patients, studies specifically assessing epidemiology and
outcomes of severe acidemia are lacking. Indeed, to our
knowledge, the current study is the first prospective,
multiple-center investigation focused specifically on
severe acidemia occurring in the ICU. Previous studies
reported an incidence of acidemia ranging from 14%
[18] to 42% [25], but most of the patients in these stu-
dies experienced moderate acidemia with a mean base
excess of -3. In a large, single-center study of 851
patients for whom arterial lactate levels were evaluated
Severe acidosis (pH<7.20) screened
(n= 200)
Ketoacidosis (n=10)
Respiratory acidosis (n=35)
Total admissions in the ICU (n= 2550) 
Medical (n= 1504)
Surgical, emergency (n= 795)
Surgical, scheduled (n= 251)
Metabolic or mixed severe 
acidosis (n= 155)
Survivors
(n= 66)
Non survivors
(n= 89)
Sepsis (n= 769)
Trauma (n= 281)
Other shock (n= 256)
Postoperative (n= 127)
Other (n= 1117)
Figure 1 Study flowchart.
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Figure 2 General features of acid-base metabolism evaluated during the first three days. (A) pH. (B) Bicarbonatemia. (C) PaCO2. (D)
Chloremia. (E) Lactatemia. (F) Corrected anion gap. *P < 0.05, Tukey’s post hoc analysis between survivors (n = 66) and nonsurvivors (n = 89).
#P
< 0.05, Tukey’s post hoc analysis vs day 0. Bars represent standard deviations. NS = not significant. PaCO2 = partial pressure of carbon dioxide.
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Page 6 of 9[12], the incidence of metabolic acidosis (defined by a
standard base excess below -2 mmol/L) was 64%. In the
present study, the incidence of metabolic or mixed
severe acidemia was 6% (Figure 1).
The patients included in our study had a mean plasma
pH of 7.09 ± 0.11 upon ICU admission. Those patients
were defined as critically ill on the basis of their SAPS II
and SOFA severity scores and the high rate of vasopres-
sor prescription and mechanical ventilation (Table 1).
Renal replacement therapy was initiated in 20% of these
patients within the first 24 hours of their ICU stay.
More than 50% of the patients died in the ICU (Tables
1 and 2). Upon ICU admission, only lactatemia and
corrected anion gap could predict mortality (Figure 2).
At day 1, plasma pH, bicarbonate and base excess were
l o w e ri nn o n s u r v i v o r st h a ni ns u r v i v o r s( F i g u r e2 ) .O u r
results are similar to those reported in a study describ-
ing acid-base disorders in 60 septic shock patients,
among whom the survivors recovered from metabolic
acidemia with correction of unmeasured anions and lac-
tate, whereas nonsurvivors failed to do so [5]. However,
the authors in that study screened the patients accord-
ing to the presence of septic shock rather than the pre-
sence and the severity of acid-base disorders and thus
could not specifically assess the prognosis of acidotic
patients [5]. Another trial included unselected patients
Table 2 Admission and outcome characteristics of the 155 patients admitted with severe metabolic or mixed acidosis
treated with buffers or not at day 0
Characteristics Sodium bicarbonate
administration
within first 24 hours of ICU stay
(n = 57)
No sodium bicarbonate
administration
within the first 24 hours of ICU stay
(n = 98)
P value
Age (years) 62 ± 16 64 ± 17 0.26
Admitting diagnosis group
Septic shock 23 (40) 31 (32) 0.30
Hemorrhagic shock 8 (14) 8 (8) 0.28
Cardiogenic shock 2 (4) 9 (9) 0.33
Cardiac arrest 5 (9) 14 (14) 0.45
Others 19 (33) 36 (37) 0.73
SAPS II upon ICU admission 71 ± 23 64 ± 22 0.10
SOFA upon ICU admission 11 ± 4 10 ± 4 0.15
Vasopressor administration upon ICU admission 49 (86) 81 (83) 0.65
Mechanical ventilation upon ICU admission 30 (52) 54 (55) 0.86
Renal replacement therapy within first 24 hours of ICU stay 15 (26) 16 (17) 0.20
Plasma pH upon ICU admission 7.07 ± 0.15 7.10 ± 0.09 0.39
Bicarbonatemia upon ICU admission (mmol/L) 12.6 ± 5.2 15.4 ± 5.6 < 0.01
PaCO2 upon ICU admission (mmHg) 41.6 ± 12.6 52.1 ± 22.8 < 0.01
Base excess upon ICU admission (mmol/L) -15.6 ± 6.3 -12.5 ± 5.7 < 0.01
Anion gap corrected upon ICU admission (mmol/L) 31 ± 11 26 ± 8 0.02
Lactatemia upon ICU admission (mmol/L) 9.3 ± 6.9 7.8 ± 5.5 0.32
Length of vasopressor treatment (days) 3.9 ± 4.7 5.3 ± 8.8 0.35
Length of mechanical ventilation (days) 6.6 ± 10.7 8.3 ± 14.0 0.85
ICU length of stay (days) 10.1 ± 15.5 11.4 ± 15.7 0.32
Mortality in the ICU 34 (60) 55 (56) 0.73
PaCO2 = partial pressure of carbon dioxide; SAPS II: Severity Acute Physiology Score II [22]; SOFA = Sequential Organ Failure Assessment [23]. Categorical data
are expressed as raw numbers (%). Continuous data are expressed as means ± SD.
Table 3 Multivariate logistic regression analysis for mortality analysis: results of stepwise selection procedures
Characteristics Coefficient SEM Odds ratio 95% CI P value
SAPS II above 65 upon ICU admission
a 2.01 0.61 7.53 2.30 to 24.7 < 0.001
Lactatemia upon ICU admission (mmol/L) 0.18 0.08 1.20 1.04 to 1.39 0.01
Plasma pH difference below 0.10 between day 1 and day 0
a -1.74 0.59 0.18 0.05 to 0.56 0.003
SAPS II: Severity Acute Physiology Score II [22]. Variables entered into the model were those significantly different between survivors and nonsurvivors in the
univariate analysis (Table 1 and Figure 2) upon ICU admission: age above 65 years, SAPS II above 65, SOFA above 10, anion gap, base excess, effective strong ion
difference, albuminemia, lactatemia and administration of vasopressors. Plasma level difference between day 1 and day 0 for pH, bicarbonate and base excess
and the amount of sodium bicarbonate (in mmol/kg) that were administered within the first 24 hours of ICU stay were also entered into the model.
aDiscretized
according to median value.
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ICU admission was associated with mortality [25]. The
association between base excess and mortality was mag-
nified after 24 hours of intensive resuscitation, thus
showing the importance of acid-base disorder correction
clearance in the critically ill.
In our present study focused on severe metabolic and
mixed acidemia, we report that, as opposed to the pH
value upon ICU admission, the rapidity of pH recovery
was associated with mortality (Table 3). Whether meta-
bolic acidemia is an etiologic contributor to organ dys-
function or just a marker of illness has been debated.
Recent findings demonstrate that severe metabolic acid-
emia is at least a contributory factor to organ dysfunc-
tion, favoring cardiac output decrease, arterial dilatation
with hypotension, arrhythmia, altered oxygen delivery,
respiratory muscle workload increase in spontaneously
breathing patients, decreased ATP production and
impairment of the immune response [3,16]. Acidemia
correction using the administration of a base, primarily
in the form of sodium bicarbonate, has naturally become
the mainstay of therapy [26,27], but its use continues to
generate intense debate [2,28,29]. In our study, we
included patients with severe academia, and the pre-
scription of sodium bicarbonate was heterogeneous
between the participating ICUs and independent of the
mechanism of academia, as shown by chloremia and
corrected anion gap values upon ICU admission (Table
1). Lower PaCO2, bicarbonatemia and base excess were
associated with sodium bicarbonate prescription. Inter-
estingly, our results are similar to those of a recent
North American survey which reported that over 60% of
intensivists and 80% of nephrologists would consider the
use of buffer therapy for the treatment of lactic acidosis
[8]. To our knowledge, that survey and our present
study are the only investigations that describe the pat-
tern of sodium bicarbonate prescription for severe acid-
emia in critically ill patients.
When prescribing sodium bicarbonate in the critically
ill, the potential side effects of severe acidemia must be
balanced with complications related to sodium bicarbo-
nate itself. Indeed, sodium bicarbonate may also be
associated with complications such as a transient drop
in blood pressure and cardiac output and a decrease in
ionized calcium, thus sensitizing the heart to abnormal
electrical activity and subsequent arrhythmia [2,3,29].
Moreover, “paradoxical” intracellular acidosis may occur
because generated CO2 freely diffuses across the cell
membrane [2,3,29,30]. In addition, bicarbonate adminis-
tration can be responsible for hypernatremia, volume
overload, the release of proinflammatory cytokines [31]
and apoptosis [29]. In the present study, administration
of sodium bicarbonate within the first 24 hours of acide-
mia was not associated with outcome (Tables 2 and 3).
In 2011, there is no human study that has reported
any beneficial or detrimental effects of sodium bicarbo-
nate administration when treating patients with severe
mixed or metabolic acidemia. Therefore, attention
should be first directed toward correcting the underlying
basis for the acidemia.
Conclusions
This study reports for the first time that severe meta-
bolic or mixed acidemia, defined by plasma pH lower
than 7.20, occurs within the first 24 hours in the ICU in
6% of critically ill patients. In our study, severe acidemia
was associated with a high mortality rate, and, rather
than the initial pH value, the rapidity of acidemia cor-
rection appeared to be a determinant of outcome.
Sodium bicarbonate therapy administration was very
heterogeneous between participating ICUs. Further stu-
dies are necessary to better assess the role of buffers in
this subgroup of critically ill patients.
Key messages
◆ Severe metabolic and/or mixed acidemia (pH <
7.20) occurred in 6% of patients during the study
period in the five participating ICUs.
◆ Severe metabolic and/or mixed acidemia was asso-
ciated with 57% mortality in the ICU.
◆ Rather than the initial pH value, the rapidity of
acidemia correction appeared determine patient
outcomes.
◆ Sodium bicarbonate was prescribed for 37% of the
patients, was heterogeneous between the participat-
ing ICUs and was independent of the mechanism of
acidemia.
Additional material
Additional file 1: Figure S1. Individual values of pH, bicarbonatemia,
lactatemia and base excess in survivors and nonsurvivors within the first
24 hours of the ICU stay.
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